{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:30:48Z","timestamp":1785933048368,"version":"3.56.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.autrev.2024.103605","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T05:05:53Z","timestamp":1724475953000},"page":"103605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immune thrombocytopenia (ITP) - could it be part of autoimmune\/inflammatory syndrome induced by adjuvants (ASIA)?"],"prefix":"10.1016","volume":"23","author":[{"given":"Paula","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle de Mello","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan Shneor","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda A.","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.autrev.2024.103605_bb0005","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.autrev.2024.103605_bb0010","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2141.2009.07717.x","article-title":"Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and\/or decreased platelet production","volume":"146","author":"Nugent","year":"2009","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0020","first-page":"187","article-title":"Platelet destruction in immune thrombocytopenia","volume":"36","author":"Bakchoul","year":"2016","journal-title":"Understand Mech Hamostaseol"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro","volume":"102","author":"Chang","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/asheducation.V2012.1.306.3798320","article-title":"Pathogenesis in immune thrombocytopenia: new insights","volume":"2012","author":"Johnsen","year":"2012","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0045","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.autrev.2024.103605_bb0050","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1182\/blood-2012-05-432575","article-title":"Defective regulatory B-cell compartment in patients with immune thrombocytopenia","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103605_bb0055","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1053\/j.seminhematol.2013.03.018","article-title":"CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia","volume":"50","author":"Nishimoto","year":"2013","journal-title":"Semin Hematol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103605_bb0060","first-page":"914","article-title":"Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura","volume":"90","author":"Wang","year":"2005","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.autrev.2024.103605_bb0065","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.thromres.2006.09.008","article-title":"Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura","volume":"120","author":"Sakakura","year":"2007","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 \u2013 autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103605_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0090","first-page":"516","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvant associated with a metal implant in the mouth; explantation was followed by recovery","volume":"22","author":"Kagan","year":"2020","journal-title":"Isr Med Assoc J (IMAJ)"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa481","article-title":"A possible association of orthopedic metal implants and ASIA syndrome","volume":"60","author":"Schiff","year":"2021","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2024.103605_bb0110","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/jcp.45.11.1037","article-title":"Severe thrombocytopenia secondary to asymptomatic cytomegalovirus infection in an immunocompetent host","volume":"45","author":"Wright","year":"1992","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2141.2008.07275.x","article-title":"Refractory immune thrombocytopenic purpura: current strategies for investigation and management","volume":"143","author":"Psaila","year":"2008","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103605_bb0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/17474086.2020.1772746","article-title":"Comparative study between chronic immune thrombocytopenia patients and healthy population on Epstein-Barr virus infection status by polymerase chain reaction","volume":"13","author":"Yan","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0955-3886(98)00039-3","article-title":"Virus-associated idiopathic thrombocytopenic purpura","volume":"19","author":"Rand","year":"1998","journal-title":"Transfus Sci"},{"key":"10.1016\/j.autrev.2024.103605_bb0130","article-title":"SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports","author":"Ono","year":"2024","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0135","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinternmed.2008.576","article-title":"Risk of immune thrombocytopenic Purpura and autoimmune hemolytic Anemia among 120 908 US veterans with hepatitis C virus infection","volume":"169","author":"Chiao","year":"2009","journal-title":"Arch Intern Med"},{"issue":"28","key":"10.1016\/j.autrev.2024.103605_bb0145","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.3748\/wjg.v26.i28.4076","article-title":"Helicobacter pylori infection: beyond gastric manifestations","volume":"26","author":"Santos","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0150","first-page":"139","article-title":"Prevalence of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) subclinical infection in patients with acute immune thrombocytopenic Purpura (ITP)","volume":"15","author":"Abbasi","year":"2021","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2141.2009.08064.x","article-title":"CMV-related immune thrombocytopenic purpura or CMV-induced thrombocytopenia?","volume":"149","author":"Papagianni","year":"2010","journal-title":"Br J Haematol"},{"issue":"13","key":"10.1016\/j.autrev.2024.103605_bb0160","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2169\/internalmedicine.51.7193","article-title":"Severe steroid-resistant thrombocytopenia secondary to cytomegalovirus infection in an immunocompetent adult","volume":"51","author":"Sugioka","year":"2012","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0165","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12288-018-0945-x","article-title":"Thrombocytopenia in infants: CMV-related ITP or CMV-related thrombocytopenia?","volume":"34","author":"Isleyen","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"10","key":"10.1016\/j.autrev.2024.103605_bb0170","article-title":"A case of cytomegalovirus infection with severe thrombocytopenia in an infant who was successfully managed with antiviral therapy","volume":"14","author":"Echcharii","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1442-200X.1994.tb03215.x","article-title":"Acute thrombocytopenic purpura associated with primary Epstein-Barr virus infection","volume":"36","author":"Kanegane","year":"1994","journal-title":"Acta Paediatr Jpn"},{"issue":"12","key":"10.1016\/j.autrev.2024.103605_bb0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3324\/haematol.2011.055830","article-title":"Immune thrombocytopenia in children and adults: what\u2019s the same, what\u2019s different?","volume":"96","author":"Schulze","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0185","article-title":"Severe thrombocytopenia in a case of Epstein-Barr virus-induced infectious mononucleosis","volume":"13","author":"Zhang","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0190","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1440-1754.2000.00539.x","article-title":"Epstein-Barr virus associated with immune thrombocytopenic purpura in childhood: a retrospective study","volume":"36","author":"Hsiao","year":"2000","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajh.2830380210","article-title":"Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis","volume":"38","author":"Cyran","year":"1991","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0200","first-page":"270","article-title":"Varicella-associated thrombocytopenia: clues to the etiology of childhood idiopathic thrombocytopenic purpura","volume":"146","author":"Yeager","year":"1980","journal-title":"Johns Hopkins Med J"},{"issue":"23","key":"10.1016\/j.autrev.2024.103605_bb0205","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.2169\/internalmedicine.53.3091","article-title":"Relapse of immune thrombocytopenia associated with varicella 20 years after splenectomy","volume":"53","author":"Yoshida","year":"2014","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0210","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1651-2227.2010.01842.x","article-title":"Post-varicella thrombocytopenic purpura","volume":"99","author":"Amir","year":"2010","journal-title":"Acta Paediatr"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcma.2011.08.010","article-title":"Acute immune thrombocytopenic purpura in an adolescent with 2009 novel H1N1 influenza A virus infection","volume":"74","author":"Lee","year":"2011","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0220","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/fcp.12213","article-title":"Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection","volume":"30","author":"Bigot","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0230","first-page":"378","article-title":"Immune thrombocytopenic Purpura (ITP) triggered by COVID-19 infection and vaccination","volume":"23","author":"David","year":"2021","journal-title":"Isr Med Assoc J"},{"issue":"18","key":"10.1016\/j.autrev.2024.103605_bb0235","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Jie","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0240","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","article-title":"Mechanism of thrombocytopenia in COVID-19 patients","volume":"99","author":"Xu","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.autrev.2024.103605_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/ijpvm.ijpvm_377_21","article-title":"Changes in the level of antiphospholipid antibodies (Anticardiolipin and anti-\u03b22-glycoprotein-I) and thromboembolic indices in COVID-19 patients during 3 weeks","volume":"14","author":"Haghighipour","year":"2023","journal-title":"Int J Prev Med"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0255","first-page":"536","article-title":"Immune thrombocytopenic Purpura associated with hepatitis A infection in A five-year old boy: A case report","volume":"63","author":"Urganci","year":"2014","journal-title":"West Indian Med J"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0260","first-page":"89","article-title":"Immune thrombocytopenic Purpura and hemolytic Anemia secondary to hepatitis A","volume":"11","author":"Miri-Aliabad","year":"2017","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0265","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/bjh.17977","article-title":"Significance of anti-HBc serological status in primary immune thrombocytopenia","volume":"196","author":"Wang","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2024.103605_bb0270","first-page":"1","article-title":"Immune thrombocytopenia associated with hepatitis B virus and autoimmune hepatitis and recovery of platelet count following liver transplantation","volume":"2021","author":"Nobuhara","year":"2021","journal-title":"Case Rep Transplant"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0275","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0168-8278(01)00207-0","article-title":"Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity","volume":"35","author":"Toubi","year":"2001","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103605_bb0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinternmed.2008.576","article-title":"Risk of immune thrombocytopenic Purpura and autoimmune hemolytic Anemia among 120 908 US veterans with hepatitis C virus infection","volume":"169","author":"Chiao","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0285","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103605_bb0290","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.V98.8.2293","article-title":"The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines","volume":"98","author":"Hamaia","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0973-6883(11)60124-2","article-title":"Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India","volume":"1","author":"Varma","year":"2011","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0300","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2005.00524.x","article-title":"Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon- \u03b1 therapy: possible etiology of HCV-associated immune thrombocytopenia","volume":"75","author":"Iga","year":"2005","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200303000-00003","article-title":"Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases","volume":"82","author":"Ramos-Casals","year":"2003","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0315","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0043-1772771","article-title":"Review: advances in the pathogenesis and treatment of immune thrombocytopenia associated with viral hepatitis","volume":"10","author":"Xu","year":"2023","journal-title":"Glob Med Genet"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0320","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood.V91.9.3239","article-title":"Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients","volume":"91","author":"Cole","year":"1998","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.autrev.2024.103605_bb0325","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1073\/pnas.94.14.7589","article-title":"GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia","volume":"94","author":"Nardi","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0330","first-page":"415","article-title":"The mechanism of thrombocytopenia in patients with HIV infection","volume":"123","author":"Najean","year":"1994","journal-title":"J Lab Clin Med"},{"issue":"8","key":"10.1016\/j.autrev.2024.103605_bb0335","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2200836","article-title":"Clinical features and treatment effect of HIV-associated immune thrombocytopenia-single center ten-years data summary","volume":"34","author":"Tan","year":"2023","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0345","first-page":"49","article-title":"Detection of anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP) and in patients with rubella and herpes group viral infections","volume":"44","author":"Kahane","year":"1981","journal-title":"Clin Exp Immunol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2024.103605_bb0350","first-page":"55","article-title":"Thrombocytopenic purpura during the incubation period of rubella","volume":"41","author":"Amitai","year":"1986","journal-title":"Helv Paediatr Acta"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0355","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10875-007-9111-1","article-title":"Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic Purpura","volume":"27","author":"Guo","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103605_bb0360","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/asheducation-2008.1.206","article-title":"Helicobacter pylori and chronic ITP","author":"Stasi","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.autrev.2024.103605_bb0365","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1182\/blood-2006-12-063222","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles","volume":"110","author":"Emilia","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0370","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12185-008-0247-4","article-title":"Cross-reaction of antibody against helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura","volume":"89","author":"Bai","year":"2009","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2141.2003.04735.x","article-title":"Molecular mimicry by helicobacter pylori CagA protein may be involved in the pathogenesis of H. Pylori -associated chronic idiopathic thrombocytopenic purpura","volume":"124","author":"Takahashi","year":"2004","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103605_bb0380","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1182\/blood-2006-12-062695","article-title":"Platelet-bound lipopolysaccharide enhances fc receptor-mediated phagocytosis of IgG-opsonized platelets","volume":"109","author":"Semple","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jac\/dkm195","article-title":"Effect of helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Franchini","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12876-023-02664-z","article-title":"Eradication therapy may decrease the risk of immune thrombocytopenia after helicobacter pylori infection: a retrospective cohort study in Taiwan","volume":"23","author":"Koseki","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103605_bb0395","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0072-2023","article-title":"Immune thrombocytopenia associated with lymph node tuberculosis: a case report","volume":"56","author":"Vargas","year":"2023","journal-title":"Rev Soc Bras Med Trop"},{"issue":"10","key":"10.1016\/j.autrev.2024.103605_bb0400","article-title":"Immune thrombocytopenic Purpura and its rare association with a Brucella infection: A case report","volume":"14","author":"Qiu","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2024.103605_bb0405","series-title":"International journal of infectious diseases: IJID: Official publication of the International Society for Infectious Diseases. Canada","first-page":"243","article-title":"ITP following vaccination","volume":"vol. 99","author":"David","year":"2020"},{"key":"10.1016\/j.autrev.2024.103605_bb0410","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.autrev.2024.103605_bb0415","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity--friends or foes?","volume":"30","author":"Kivity","year":"2009","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0420","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12016-007-8048-8","article-title":"Infections and autoimmunity: a panorama","volume":"34","author":"Pordeus","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103605_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects","volume":"47","author":"Perricone","year":"2013","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.autrev.2024.103605_bb0430","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203316686406","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome) - an update","volume":"26","author":"Watad","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103605_bb0435","series-title":"Adverse Reactions to Human Papillomavirus Vaccines. Vaccines and Autoimmunity","first-page":"163","author":"Tomljenovic","year":"2015"},{"key":"10.1016\/j.autrev.2024.103605_bb0440","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/j.seminhematol.2016.04.014","article-title":"Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine","volume":"53","author":"Bizjak","year":"2016","journal-title":"Semin Hematol"},{"issue":"26","key":"10.1016\/j.autrev.2024.103605_bb0445","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2024.103605_bb0450","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0455","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-011-1184-3","article-title":"Drug-induced immune thrombocytopaenia: results from the Berlin case-control surveillance study","volume":"68","author":"Garbe","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103605_bb0460","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.4161\/hv.24847","article-title":"Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV)","volume":"9","author":"Qiang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0465","article-title":"HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature","volume":"59","author":"Genovese","year":"2018","journal-title":"J Prev Med Hyg"},{"issue":"6","key":"10.1016\/j.autrev.2024.103605_bb0470","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09537104.2011.633179","article-title":"Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database","volume":"23","author":"Moulis","year":"2012","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0475","article-title":"Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine","volume":"13","author":"Malayala","year":"2021","journal-title":"Cureus [Internet]"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0480","article-title":"Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine","volume":"96","author":"Tarawneh","year":"2021","journal-title":"Am J Hematol [Internet]"},{"key":"10.1016\/j.autrev.2024.103605_bb0485","unstructured":"Xu LW, Cao F, Tong RF, Wang CY, Zhang YH. [Relationship between coronavirus disease 2019 vaccination and the risk of immune thrombocytopenia]. Zhongguo Dang Dai Er Ke Za Zhi n.d. 25(9):966\u201370."},{"issue":"7","key":"10.1016\/j.autrev.2024.103605_bb0490","article-title":"Comparative analysis of De novo immune thrombocytopenia following mRNA COVID-19 vaccine versus non-mRNA vaccines and COVID-19: A global database analysis","volume":"15","author":"Mericliler","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0495","article-title":"Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study","volume":"19","author":"Xu","year":"2024","journal-title":"Open Med (Wars)"},{"issue":"9","key":"10.1016\/j.autrev.2024.103605_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.7872","article-title":"Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease-2019 vaccine: A case report","volume":"11","author":"Seyedi","year":"2023","journal-title":"Clin Case Reports"},{"key":"10.1016\/j.autrev.2024.103605_bb0505","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2023.11.007","article-title":"Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination","volume":"264","author":"Zhan","year":"2023","journal-title":"Immunol Lett"},{"issue":"12","key":"10.1016\/j.autrev.2024.103605_bb0510","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/ggi.14737","article-title":"Immune thrombocytopenic purpura in an elderly patient with cerebral hemorrhage after the fourth mRNA-1273 COVID-19 vaccination","volume":"23","author":"Kobayashi","year":"2023","journal-title":"Geriatr Gerontol Int"},{"issue":"12","key":"10.1016\/j.autrev.2024.103605_bb0515","article-title":"A successfully treated COVID-19 vaccine induced immune thrombocytopenic Purpura","volume":"15","author":"Rodriguez Guerra","year":"2023","journal-title":"Cureus"},{"issue":"49","key":"10.1016\/j.autrev.2024.103605_bb0520","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunisation with influenza A\/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.autrev.2024.103605_bb0525","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2013.09.074","article-title":"Immunogenicity and safety of Fluzone(\u00ae) intradermal and high-dose influenza vaccines in older adults \u226565 years of age: a randomized, controlled, phase II trial","volume":"32","author":"Tsang","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.autrev.2024.103605_bb0530","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.autrev.2016.07.030","article-title":"From HBV to HPV: designing vaccines for extensive and intensive vaccination campaigns worldwide","volume":"15","author":"Kanduc","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2024.103605_bb0535","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000502889","article-title":"Human papillomavirus epitope mimicry and autoimmunity: the molecular truth of peptide sharing","volume":"86","author":"Kanduc","year":"2019","journal-title":"Pathobiology"},{"issue":"5","key":"10.1016\/j.autrev.2024.103605_bb0540","article-title":"A case of vancomycin-induced immune thrombocytopenia","volume":"12","author":"MacDougall","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0545","article-title":"A rare case of vancomycin-induced immune thrombocytopenia","volume":"14","author":"Hameed","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.autrev.2024.103605_bb0550","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tmrv.2013.05.005","article-title":"Approach to the diagnosis and management of drug-induced immune thrombocytopenia","volume":"27","author":"Arnold","year":"2013","journal-title":"Transfus Med Rev"},{"issue":"7","key":"10.1016\/j.autrev.2024.103605_bb0555","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/1060028014529929","article-title":"Moxifloxacin-induced immune-mediated thrombocytopenia in a chronic kidney disease patient receiving hemodialysis","volume":"48","author":"Mailman","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.autrev.2024.103605_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111606","article-title":"PD-1\/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review","volume":"129","author":"Moore","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103605_bb0565","article-title":"Acute isolated thrombocytopenia secondary to meloxicam use: A case report","volume":"14","author":"Abdelsayed","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.autrev.2024.103605_bb0570","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31138\/mjr.28.2.64","article-title":"The ASIA syndrome: basic concepts","volume":"28","author":"Watad","year":"2017","journal-title":"Mediterr J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722400096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722400096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T05:02:01Z","timestamp":1726376521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722400096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S156899722400096X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103605","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune thrombocytopenia (ITP) - could it be part of autoimmune\/inflammatory syndrome induced by adjuvants (ASIA)?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103605"}}